Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print ACTOS (PIOGLITAZONE): NEW THERAPY FOR TYPE 2 DIABETES WITH NOVEL MODE OF ACTION LAUNCHED IN UK

ACTOS (PIOGLITAZONE): NEW THERAPY FOR TYPE 2 DIABETES WITH NOVEL MODE OF ACTION LAUNCHED IN UK

November 07, 2000

“Type 2 diabetes is characterised by high blood sugar but also by lipid abnormalities, particularly raised triglycerides and low HDL (so-called good) cholesterol. This spectrum of metabolic imbalance related to insulin resistance together with raised blood pressure is the characteristic signature of most people with Type 2 diabetes. Any compound with the ability to improve this metabolic spectrum has great potential to improve the treatment of Type 2 diabetes” according to Professor John Betteridge, Professor of Endocrinology and Metabolism at University College, London.

Professor Betteridge added “Pioglitazone, from available scientific evidence, reduces insulin resistance helping to address these metabolic concerns”.

Takeda UK Limited today announced that ACTOS® (pioglitazone) is now available in the UK for the treatment of Type 2 diabetes mellitus.

ACTOS is approved for use in the oral combination treatment of Type 2 diabetes mellitus in patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin (in obese patients) or a sulphonylurea (in patients for whom metformin is not tolerated or contraindicated). ACTOS® is taken once daily and is available in 15 and 30 milligram tablets.

Dr David Kerr, Consultant Physician, Bournemouth Diabetes & Endocrinology Centre, The Royal Bournemouth Hospital said “The availability of pioglitazone is good news for both patients and doctors. By improving insulin sensitivity, pioglitazone in combination with metformin and a sulphonylurea significantly reduces blood glucose levels which is vital when trying to manage Type 2 diabetes. In addition, pioglitazone in combination therapy decreased triglycerides and increased high density lipoprotein cholesterol (HDL-C) with no significant effect on low density lipoprotein cholesterol (LDL-C) compared to placebo.”

It is estimated that 1.4 million people in the UK have diabetes.1 Of these, between 75% and 90% have Type 2 diabetes.1 Dr Roger Gadsby a General Practitioner in Warwick commented that “The treatment of Type 2 diabetes is largely a condition managed in primary care. Any therapy, such as pioglitazone, that is taken once a day and is easy to use will be a valuable addition to the physician’s armamentarium. I believe that pioglitazone has these characteristics.”


For further information, please contact:        
Tara Mistry (Tel: 020 7345 3419) or Helen Robinson (Tel: 020 7345 3414) at Ogilvy Public Relations Worldwide.

Note to Editors:

Type 2 diabetes
Type 2 diabetes is a chronic illness characterised by an abnormally high level of glucose (sugar) in the blood.

As Type 2 diabetes progresses, the heart, the circulation, the eyes and the kidneys can all be affected and severe complications can arise which may cause severe disability and restrict a patient’s mobility and ability to work.

The cost of treating Type 2 diabetes and its associated complications is projected to total £4.8 billion in 2000. This accounts for approximately 9% of total NHS resources.1

ACTOS®
ACTOS® is a member of the thiazolidinedione class of drugs commonly known as insulin sensitizers or glitazones. ACTOS® helps restore the body’s ability to effectively use its own insulin by reducing insulin resistance, which has been identified as a primary defect in Type 2 diabetes. By improving sensitivity to insulin, ACTOS® in combination with other antidiabetic therapies significantly reduced raised blood glucose levels.

Takeda
Takeda is the largest pharmaceutical company in Japan and is one of the world’s top 20 pharmaceutical companies.

Takeda is committed to the research and development of novel drug therapies. Takeda has been investing in research into diabetes for over 30 years and were the originators of the thiazolidinedione class of drugs and the company is constantly striving to contribute to the treatment of Type 2 diabetes.

Takeda UK Ltd. is a wholly owned subsidiary of Takeda Chemical Industries, Ltd.


References
1. Diabetes UK. Diabetes Fact Sheet. June 2000.

Date of Preparation: October 2000
AC001027b



Ogilvy Public Relations Worldwide




Related Diabetes News Articles Diabetes News and Current Diabetes Events RSS Diabetes News and Current Diabetes Events RSS
Class of diabetes drugs carries significant cardiovascular risks
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.

Not all fat is created equal
A Temple University study finds fat in obese patients is "sick" when compared to fat in lean patients.

Young Type-2 Diabetic Men Suffer Low Testosterone Levels, Study Shows
Young men with type 2 diabetes have significantly low levels of testosterone, endocrinologists at the University at Buffalo have found -- a condition that could have a critical effect on their quality of life and on their ability to father children.

Early trigger for type-1 diabetes found in mice, Stanford scientists report
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins.

Findings challenge common practice regarding glucose control for critically ill patients
An analysis of randomized trials indicates that for critically ill adults, tight glucose control is not associated with a significantly reduced risk of death in the hospital, but is associated with an increased risk of hypoglycemia, calling into question the recommendation by many professional societies for tight glucose control for these patients.

Chronic stress alters our genetic immune response
Most people would agree that stress increases your risk for illness and this is particularly true for severe long-term stresses, such as caring for a family member with a chronic medical illness.

Low cholesterol associated with cancer in diabetics
Low levels of LDL cholesterol as well as high levels are associated with cancer in patients with type 2 diabetes.

Potential diabetes treatment selectively kills autoimmune cells from human patients
In experiments using blood cells from human patients with diabetes and other autoimmune disorders, Massachusetts General Hospital (MGH) researchers have confirmed the mechanism behind a potential new therapy for type 1 diabetes.

Scientists discover leptin can also aid type 1 diabetics
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.

Nano-sized 'trojan horse' to aid nutrition
Researchers from Monash University have designed a nano-sized "trojan horse" particle to ensure healing antioxidants can be better absorbed by the human body.
More Diabetes News Articles


The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health
by T. Colin Campbell, Thomas M. Campbell II

Referred to as the "Grand Prix of epidemiology" by The New York Times, this study examines more than 350 variables of health and nutrition with surveys from 6,500 adults in more than 2,500 counties across China and Taiwan, and conclusively demonstrates the link between nutrition and heart disease, diabetes, and cancer. While revealing that proper nutrition can have a dramatic effect on reducing...



Betty Crocker's Diabetes Cookbook: Everyday Meals, Easy as 1-2-3
by Betty Crocker Editors

At last! This special cookbook puts flavor and choice back on the menu for people with diabetes and their families Betty Crocker, America's most trusted friend in the kitchen, has teamed up with the International Diabetes Center (IDC)--one of the leading medical centers--to create an indispensable source of easy-to-make recipes and up-to-the-minute food and nutrition information for the...



Good Calories, Bad Calories
by Gary Taubes

In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning science writer Gary Taubes shows us that almost everything we believe about the nature of a healthy diet is wrong.For decades we have been taught that fat is bad for us, carbohydrates better, and that the key to a healthy weight is eating less and...



The New Glucose Revolution Shopper's Guide to GI Values 2008: The Authoritative Source of Glycemic Index Values for More Than 1000 Foods (Glucose Revolution)
by Dr. Jennie Brand-Miller, Kaye Foster-Powell

Whether you’re looking to lose weight, help manage conditions like diabetes or hypertension, or simply eat for lifelong good health, adopting a low-GI diet is the scientifically proven way to reach your goal. This 2008 guide, updated with more than 500 new foods, makes it easier than ever to select smart, low-GI choices for all your meals. Featured are: The GI value for over 1,000 popular...



The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed (First Year, The)
by Gretchen Becker

After Gretchen Becker was diagnosed with type 2 diabetes in 1996, she educated herself on every aspect of this chronic condition — by reading medical and scientific books and journals, talking with doctors and listening to her own body. In 2001, she marshaled everything she had learned as a "patient-expert" into the first edition of this book, which she has now completely updated and...



There Is a Cure for Diabetes: The Tree of Life 21-Day+Program
by Gabriel Cousens

Diabetes has become a seemingly unstoppable national epidemic, affecting more than twenty million Americans. Conventional wisdom calls it incurable, but renowned Dr. Gabriel Cousens counters that claim with this breakthrough book. There Is a Cure for Diabetes lays out a three-week plan for reversing the negative genetic expression of diabetes to a physiology of health and well-being. Dr....



The Official Pocket Guide to Diabetic Exchanges
by American Diabetes Association

Every day, every meal, millions and millions of people count on the world-famous Exchange Lists for Meal Planning to make sure they're choosing the right kinds of foods and portion sizes from the various food groups. Now people with diabetes can take the Exchange Lists with them to the grocery store or to restaurants with the Official Pocket Guide to Diabetic Exchanges. Measuring just 3.5" x 6",...



Diabetes For Dummies (For Dummies (Health & Fitness))
by Alan L., MD Rubin

"The Greeks and Romans knew about diabetes. Fortunately, the way they tested for the condition--by tasting the urine--has gone by the wayside." Diabetes for Dummies has the friendly, quirky style you expect from all the For Dummies books, but this is no skim-the-surface Diabetes 101. Rubin has packed this book with useful information, peppered with warm advice for enjoying your life while living...



Dr. Bernstein's Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars
by Richard K. Bernstein

The standard text on living with diabetes, newly revised andupdated with all the latest scientific findings.Since its first publication in 1997, DR. BERNSTEIN'S DIABETES SOLUTION hasbecome the treatment of choice in the medical field. In this revised andupdated edition of his work, Dr. Bernstein provides an accessible, detailedguide to his revolutionary approach to normalizing blood sugars and...



The Insulin-Resistance Diet--Revised and Updated
by Cheryle R. Hart, Mary Kay Grossman

Conquer insulin resistance. Reduce cravings. Eat your favorite foods. And lose weight! If you have tried every diet and are still struggling with your weight, the real culprit may be insulin resistance. When you have more glucose than your body needs, your body responds by producing more insulin to stabilize your blood sugar level and store the excess glucose as fat. In The Insulin-Resistance...

© 2008 BrightSurf.com